Storage and handling
Other information • store at 20°-25°C (68°-77°F)
Other information • store at 20°-25°C (68°-77°F)
Active ingredient (in each tablet)
Guaifenesin 400 mg
Purpose
Expectorant
Use
helps loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and make coughs more productive
Warnings
Stop use and ask a doctor if
cough persists more than 7 days, tends to recur, or is accompanied by a fever, rash, or persistent headache.
These could be signs of a serious condition.
If pregnant or breast-feeding, ask a health professional before use.
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
Directions
adults and children 12 years and over | take 1 tablet every 4 hours |
children under 12 years | Do not use |
Other information
Inactive ingredients
FD&C blue no. 1 aluminum lake, hypromellose, magnesium stearate, maltodextrin, microcrystalline cellulose, polyethylene glycol, povidone, silicon dioxide, sodium starch glycolate, stearic acid
Questions or comments?
Call weekdays from 9 AM-5 PM EST at 1-800-245-1040
Do not use if safety seal under cap printed with “Sealed for Your Protection” is broken or missing.
Lift Here for More Drug Facts
Distributed by: GSK Consumer Healthcare, Warren, NJ 07059
visit
www.robitussin.com
Trademarks owned or licensed by GSK.
©2022 GSK or licensor.
Made in China
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 0031-9303 | 0031-9303-01 |
Every source-derived ingredient row is available through these pages.
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 7913f832-10b1-45e8-bc2e-8fc1ae59d817 | 5998b7dd-e376-4ea7-955e-707268e12b0b | 2024-04-12 | Warnings | 7913f832-10b1-45e8-bc2e-8fc1ae59d817 5998b7dd-e376-4ea7-955e-707268e12b0b |
Adverse event summaries are temporarily unavailable. Other product information remains available.